CD20

CD20 是一种 33-37 kDa 非糖基化蛋白,特异性表达于正常和恶性 B 淋巴细胞表面,属于 MS4A(跨膜 4 结构域家族 A)蛋白家族。CD20 是一种通用 B 细胞标记物,从晚期前 B 淋巴细胞开始,大多数 B 细胞均有表达(前 B 淋巴细胞不表达),在终末分化的浆母细胞和浆细胞中表达缺失。早期实验表明,它在调节人类 B 细胞活化、增殖和 Ca2+ 转运方面发挥重要作用。然而,CD20 缺陷小鼠似乎正常。因此,CD20 及其生理配体的确切生物学功能仍有待完全确定。240 尽管这种抗原的生物学作用尚不确定,但它是癌症免疫治疗的良好靶点。

CD20 is a 33-37 kDa non-glycosylated protein expressed specifically on the surface of normal and malignant B lymphocytes, and belongs to the MS4A (membrane-spanning 4-domain family A) protein family. CD20 is a general B-cell marker expressed by the majority of B cells starting from late pre-B lymphocytes (it is not expressed by pro-B lymphocytes), and its expression is lost in terminally differentiated plasmablasts and plasma cells. Early experiments suggested that it was important in the regulation of human B-cell activation, proliferation, and Ca2+ transport. However, CD20-deficient mice appeared normal. Hence, the exact biological function of CD20 and its physiological ligand remain to be fully defined.240 Regardless of the uncertainty in the biological role of this antigen, it is a good target for cancer immunotherapy.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Anti-Mouse CD20 Antibody (18B12)

Anti-Mouse CD20 Antibody (18B12) 是一种靶向小鼠 CD20 的 B 细胞清除剂,不仅能抑制间皮瘤、肺癌和胸腺瘤的生长,还能通过增加肿瘤特异性 CD8+ T 细胞数量显著增强腺病毒肿瘤抗原疫苗的疗效并诱导肿瘤消退,同时能够减少实验性自身免疫性脑脊髓炎小鼠中枢神经系统的 B 细胞浸润,并通过减轻炎症反应和组织损伤延缓脊髓损伤后的运动功能障碍及神经元死亡,广泛适用于间皮瘤、肺癌、胸腺瘤、实验性自身免疫性脑脊髓炎及脊髓损伤等相关领域的研究。

Antagonist
Anti-Mouse CD20 Antibody (18B12)

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础